Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys

Journal of Hypertension

Volumn 15, Issue 7, 1997, Pages 719-726

  Brosnihan, K Bridget ^a   Weddle, Diann ^a   Anthony, Mary S ^a   Heise, Clara ^a   Li, Ping ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Angiotensin peptides; Cycrin; Estrogen; Nonhuman primates; Premarin; Progestin; Renin activity

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; FEMALE; HORMONE SUBSTITUTION; LONG TERM CARE; MEAN ARTERIAL PRESSURE; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030916960     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715070-00003     Document Type: Article

References (37)

1. Stampfer MJ, Colditz GA: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Med 1991, 20:47-63.
2. Barrett-Connor E, Bush TJ: Estrogen and coronary heart disease in women. JAMA 1991, 265:1861-1867.
3. Hunt K, Vessey M, McPherson K, Coleman M: Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol 1987, 94:620-635.
4. Stampfer MJ, Colditz GA, Willett WC, Manson JAE, Rosner B, Speizer EE, et al.: Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med 1991, 325:756-762.
5. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR: Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically post-menopausal cynomolgus monkeys. J Clin Invest 1991, 88:1995-2002.
6. Williams JK, Honore EK, Washburn SA, Clarkson TB: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994, 24:1757-1761.
7. Gisclard V, Miller VM, Vanhoutte PM: Effect of 17-β estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988, 244:19-22.
8. Kauser K, Rubanyi GM: Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 1994, 267:H2311-H2317.
9. Mukow PJ, Ganong WF: Stimulation of aldosterone secretion by angiotensin II. Yale J Biol Med 1961, 33:386-395.
10. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S: Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA 1983, 80:2196-2200.
11. Brosnihan KB, Li P, Ferrario CM: Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996, 27:523-528.
12. Benter IF, Diz DI, Ferrario CM: Cardiovascular actions of angiotensin-(I-7). Peptides 1993, 14:679-684.
13. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, et al.: Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 1995, 15:827-836.
14. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM: Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 1991, 12:1135-1141.
15. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM: Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol 1994, 5:129-137.
16. Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, Waeber B, et al.: Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990, 16:56-72.
17. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990, 81:1680-1687.
18. Nasjletti A, Masson GMC: Studies on angiotensinogen formation in a liver perfusion system. Circ Res 1972, 30 (suppl II):187-202.
19. Tewksbury DA: Angiotensinogen - biochemistry and molecular biology. In Hypertension: Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990: 1197-1216.
20. Chen Y, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992, 19:456-463.
21. Rubattu S, Quimby FW, Sealey JE: Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens 1991, 9:525-535.
22. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, Sealey JE: Prorenin in high concentrations in human ovarian follicular fluid. Science 1986, 233:1422-1424.
23. Howard RB, Pucell AG, Bumpus FM, Husain A: Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology 1988, 123:2331-2340.
24. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertensive patients. Am J Hypertens 1992, 5:95-110.
25. Chen Y, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992, 19:456-463.
26. Seltzer A, Pinto JEB, Viglione PN, Correa FMA, Libertun C, Tsutsumi K, et al.: Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 1992, 55:460-4607.
27. Clauser E, Gaillard I, Wei L, Corvol P: Regulation of angiotensinogen gene. Am J Hypertens 1989, 2:403-410.
28. Iwao H, Abe Y: Expression of the renin and angiotensinogen genes [in Japanese]. Nippon Yakurigaku Zasshi 1991, 97:1-11.
29. Ohta N, Takahashi T, Mori T, Park MK, Kawashima S, Takahashi K, et al. Hormonal modulation of prolyl endopeptidase and dipeptidyl peptidas IV activities in the mouse uterus and ovary. Acta Endocrinol 1992, 127:262-266.
30. Ottlecz A, Walker S, Conrad M, Starcher B: Neutral metalloendopeptidase associated with the smooth muscle cells of pregnant rat uterus. J Cell Biochem 1991, 45:401-411.
31. Phillips MI, Wang H, Kimura B, Rejtman M, Koduri P, Kalra SP: Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone- induced luteinizing hormone surge. Endocrinology 1992, 132:1637-1642.
32. Senanayake P, Martins A, Ganten D, Brosnihan KB: Angiotensin II in the kidney of transgenic hypertensive rat is resistant to the reduced expression of the renin gene (abstract). Hypertension 1995, 25:1409
33. Schirar A, Capponi A, Catt KJ: Regulation of uterine angiotensin II receptors by estrogen and progesterone. Endocrinology 1980, 106:5-12.
34. Pettinger WA, Tanaka K, Keeton K, Campbell WB, Brooks SN: Renin release, an artifact of anesthesia and its implications in rats. Proc Soc Exp Biol Med 1975, 148:625-630.
35. Lenz T, Sealey JE, Maack T, James GD, Heinrikson RL, Marion D, et al.: Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol 1991, 260:R804-R810.
36. Itskovitz J, Bruneval P, Soubrier F, Thaler I, Corvol P, Sealey JE: Localization of renin gene expression to monkey ovarian theca cells by in situ hybridization. Clin Endocrinol Metab 1992, 75:1374-1380.
37. Barrett-Connor E, Khaw K-T: The epidemiology of DHEA-S with particular reference to cardiovascular disease: the Rancho Bernardo study. In The Biologic Role of Dehydroepiandrosterone. Edited by Kalimi M, Regelson W. Berlin: Walter de Gruyter; 1990:281-298.